Suchergebnisse - "Sang, Yun Beom"

PubPharm (8)

1

Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab

enthalten in: Journal of clinical medicine | 2024

von Sang, Y. | Lee, C. | Kim, S. | +4

2

Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma

enthalten in: Liver cancer | 2024

von Song, Y. | Yang, H. | Kang, B. | +10

3

Dramatic Response to Cabozantinib in a Patient with Refractory Hepatocellular Carcinoma with c-MET Amplification

enthalten in: Journal of clinical and translational hepatology | 2023

von Sang, Y. | Kim, G. | Hwang, S. | +2

4

High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma

enthalten in: Journal of Cancer | 2023

von Kim, Y. | Yang, H. | Lee, W. | +5

5

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma

enthalten in: Cancers | 2022

von Sang, Y. | Yang, H. | Lee, W. | +7

6

The Development of AXL Inhibitors in Lung Cancer : Recent Progress and Challenges

enthalten in: Frontiers in oncology | 2022

von Sang, Y. | Kim, J. | Kim, C. | +4

7

Combining Cancer Vaccines with Immunotherapy : Establishing a New Immunological Approach

enthalten in: International journal of molecular sciences | 2021

von Kim, C. | Sang, Y. | Lee, J. | +1

8

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers : a multicenter retrospective analysis

enthalten in: Therapeutic advances in medical oncology | 2021

von Cheon, J. | Lee, C. | Sang, Y. | +10

1
[1]